Skip to main content

Table 5 Number and cellular origin of circulating Microparticles in patients with ACS (n = 22)

From: Plasma TF activity predicts cardiovascular mortality in patients with acute myocardial infarction

 

ACS (n = 22)

Annexin+ Microparticles, (103/μl)

9.7 ± 3.85

   %TF positive

56.8 ± 5.01

   %CD41 positive

13.4 ± 2.19

   %CD66 positive

15.0 ± 3.22

   %CD66/CD41 double positive

49.2 ± 6.4

Annexin+ TF+ Microparticles, (103/μl)

5.2 ± 2.26

   %CD41 positive

10.6 ± 1.65

   %CD66 positive

9.8 ± 3.22

   %CD66/CD41 double positive

64.5 ± 5.00